International Patent: MODIFIED PFCYRPA PROTEINS AND THEIR USE AS BLOOD-STAGE MALARIA VACCINE IMMUNOGENS.

GENEVA, Sept. 18 -- OXFORD UNIVERSITY INNOVATION LIMITED filed a patent application (GB2026/050317) for “MODIFIED PFCYRPA PROTEINS AND THEIR USE AS BLOOD-STAGE MALARIA VACCINE IMMUNOGENS.”. With publication no. WO/2026/185545, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/015

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....